3-bromododecane | 149429-86-7

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 有机溴化物
• 英文名称: 3-bromododecane
• 英文别名: 3-Bromdodecan
• CAS: 149429-86-7
• 化学式: C₁₂H₂₅Br
• 分子量: 249.234
• InChiKey: RSNSXFVJHAVRKA-UHFFFAOYSA-N

物化性质

• 沸点：
  271.6±8.0 °C(Predicted)
• 密度：
  1.037±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  6.4
• 重原子数：
  13
• 可旋转键数：
  9
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  亚磷酸二丁酯 、 3-bromododecane 生成 Dodecan-phosphonsaeure-⁽³⁾-dibutylester
  参考文献：
  名称：

  Geiseler,G. et al., Chemische Berichte, 1960, vol. 93, p. 765 - 774

  摘要：

  DOI：
• 作为产物：
  描述：

  十二烷 在 CuBr*Bu₄NBr 四溴化碳 作用下， 反应 5.0h， 生成 2-溴十二烷 、 5-Bromododecane 、 4-bromododecane 、 3-bromododecane
  参考文献：
  名称：

  摘要：

  Quantitative catalytic bromination of alkanes, cycloalkanes, and arylalkanes with carbon tetrabromide as brominating agent was accomplished for the, first time.

  DOI：

  10.1023/a:1020889209717

文献信息

• Compound, photocurable composition, cured product of same, printing ink, and printed matter curing the printing ink
  申请人：DIC Corporation

  公开号：US11079675B2

  公开（公告）日：2021-08-03

  A novel compound is used as a novel photopolymerization initiator, the novel compound having a molecular structure represented by general formula 1 below [R1 represents an alkyl group having 1 to 10 carbon atoms, R2 represents an alkyl group having 1 to 12 carbon atoms or the like, R3 represents an alkyl group having 1 to 12 carbon atoms or the like, R4 to R7 each independently represent a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, or the like, Y1 represents an alkyl group having 3 to 19 carbon atoms or the like, Y2 represents an organic linking group, X1 represents an ethylene group or the like, X2 and X3 each represent an ethylene group or the like, Y3 represents a single bond or an alkylidene group, and n represents an integer of 1 to 3].

  一种新型化合物被用作新型光聚合引发剂，该新型化合物的分子结构如下通式 1 所示 [R1 代表具有 1 至 10 个碳原子的烷基，R2 代表具有 1 至 12 个碳原子的烷基或类似物，R3 代表具有 1 至 12 个碳原子的烷基或类似物，R4 至 R7 各自独立地代表氢原子、具有 1 至 8 个碳原子的烷基或类似物、Y1 代表具有 3 至 19 个碳原子的烷基或类似基团，Y2 代表有机连接基团，X1 代表乙烯基或类似基团，X2 和 X3 各自代表乙烯基或类似基团，Y3 代表单键或亚烷基，n 代表 1 至 3 的整数]。
• Enhanced ultrasound detection with temperature-dependent contrast agents
  申请人：——

  公开号：US20020102216A1

  公开（公告）日：2002-08-01

  Methods and devices for enhanced ultrasound detection based upon changing temperature and ultrasound reflectivity of a temperature-dependent contrast agent bound to an ultrasound target are disclosed. The methods and devices can be used for enhanced imaging alone or in conjunction with drug delivery, with therapeutic approaches such as hyperthermia or cryotherapy or with other imaging modalities.

  本发明公开了根据温度变化和与超声目标结合的温度依赖性造影剂的超声反射率增强超声检测的方法和装置。这些方法和设备可单独用于增强成像，也可与给药、热疗或冷冻疗法等治疗方法或其他成像模式结合使用。
• Emulsion particles for imaging and therapy and methods of use thereof
  申请人：Lanza M. Gregory

  公开号：US20050079131A1

  公开（公告）日：2005-04-14

  Emulsions preferably of nanoparticles formed from oil compounds coupled to a high Z number atom, said particles coated with a lipid/surfactant coating. The nanoparticles are made specific to targeted cells or tissues by coupling said nanoparticles to a ligand specific for the target cells or tissues. The nanoparticles may further include biologically active agents, radionuclides and/or other imaging agents.

  最好是由与高 Z 数原子偶联的油化合物形成的纳米颗粒的乳液，所述颗粒涂有脂质/表面活性剂涂层。通过将纳米颗粒与目标细胞或组织的特异性配体偶联，使纳米颗粒对目标细胞或组织具有特异性。纳米粒子可进一步包括生物活性剂、放射性核素和/或其他成像剂。
• Enhanced drug delivery
  申请人：Lanza M. Gregory

  公开号：US20050175541A1

  公开（公告）日：2005-08-11

  The invention is directed to methods for the delivery of a therapeutic agent using lipid-encapsulated particles containing the therapeutic agent and ultrasound energy. For example, it particularly relates to the use of ultrasound with a lipid-encapsulated emulsion comprising an oil where the emulsion is coupled a targeting ligand and comprises a therapeutic agent.

  本发明涉及利用含有治疗剂的脂质包囊颗粒和超声波能量输送治疗剂的方法。例如，本发明特别涉及超声波与包含油脂的脂质包封乳液的使用，其中乳液耦合了靶向配体并包含治疗剂。
• A pretreatment method for blood analysis
  申请人：Sysmex Corporation

  公开号：EP0598663B1

  公开（公告）日：2000-02-02